Camrelizumab Combined With Apatinib in the Treatment of Epithelial Ovarian Cancer
Clinical trial NCT04507750 · UNKNOWN
Trial details
- NCT number
- NCT04507750
- Sponsor
- Qianfoshan Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-10
- Primary completion
- 2021-08-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.